Atlantic Edge Private Wealth Management’s Vaxcyte PCVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.42K Hold
25
– – ﹤0.01% 584
2026
Q2
$1.45K Hold
25
– – ﹤0.01% 576
2026
Q1
$1.45K Hold
25
– – ﹤0.01% 553
2025
Q4
$1.15K Buy
+25
New +$1.12K ﹤0.01% 549

Other funds holding PCVX

Atlantic Edge Private Wealth Management's PCVX Position: Q3 2026 in Review

Atlantic Edge Private Wealth Management held its Vaxcyte (PCVX) position steady in Q3 2026 at 25 shares worth $1.42K. The position accounts for ﹤0.01% of the portfolio, ranked #584.

Atlantic Edge Private Wealth Management first reported a position in PCVX in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.45K in Q2 2026. 356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.

  • Atlantic Edge Private Wealth Management held 25 shares of Vaxcyte worth $1.42K as of Q3 2026.
  • Atlantic Edge Private Wealth Management left its Vaxcyte share count unchanged in Q3 2026.
  • Vaxcyte made up ﹤0.01% of Atlantic Edge Private Wealth Management's portfolio in Q3 2026, its #584 holding.
  • Atlantic Edge Private Wealth Management first reported a position in Vaxcyte in Q4 2025 and has held it in 4 quarters since.
  • Atlantic Edge Private Wealth Management's Vaxcyte position peaked at $1.45K in Q2 2026.
  • 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.